Podcast

Share

Program Content

Activities

  • Oral SERDS for HR+/HER2 Neg ESR1m MBC
    Clinical Highlights: Oral SERDs for Patients With HR+/HER2- ESR1-Mutated Advanced Breast Cancer
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 31, 2025

    Expires: July 30, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from AstraZeneca and Lilly

AstraZeneca

Lilly